Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of Moderate Buy by Brokerages

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong […]

Related Keywords

Leerink Partnrs ,Nasdaq ,York Mellon Corp ,Relay Therapeutics Inc ,Relay Therapeutics Company Profile ,Great West Life Assurance Co ,Metlife Investment Management ,Dimensional Fund Advisors ,Relay Therapeutics ,Get Free Report ,New York Mellon Corp ,Life Investment Management ,West Life Assurance ,Get Free ,Relay Therapeutics Daily ,Nasdaq Rlay ,Arlay ,Medical ,Ratings ,Consensus ,